Medicamentos de molécula pequeña

 
 
Solicitar información

Productos y servicios de gran calidad


El desarrollo de un nuevo producto farmacéutico es un proceso complejo y exigente. Como el líder en productos y servicios de gran calidad para las industrias química y farmacéutica, ofrecemos todo lo que usted necesita para optimizar el desarrollo y reducir el tiempo transcurrido hasta la comercialización.

Y con nuestros exhaustivos Expedientes EMPROVE®, proporcionamos documentación detallada y específica de uso sobre una creciente variedad de materias primas farmacéuticas, para una mayor seguridad, así como un considerable ahorro de tiempo y coste.
  • Una cartera de productos en continua actualización para mercados y requisitos normativos en evolución.
  • Una amplia gama de servicios centrados en el cliente
  • Cantidades de producción a medida a una escala global
  • Equipo y conocimientos especializados de vanguardia apoyados por una matriz completa de tecnologías de producción, capaces de cubrir más del 95 % de todas las reacciones químicas habituales.
  • Un servicio completo durante toda la cadena de desarrollo apoyándole en aspectos químicos y regulatorios.
  • Plantas de producción y desarrollo con certificación de cGMP e inspeccionados por la FDA

Nuevas notas de prensa

18-abr-2018
Merck Wins INTERPHEX Exhibitor Award for Best Technological Innovation

Merck today announced that its Millistak+® HC Pro portfolio has won an INTERPHEX Exhibitor Award for Best Technological Innovation.

20180418 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
17-abr-2018
Merck Introduces New Single-use Technologies to Advance Flexible Manufacturing

Merck today introduced three new products to support flexible manufacturing of biologics.

20180417
12-abr-2018
Merck Helps Accelerate Global Access to Affordable Vaccines

Merck today announced a partnership with Oxford University’s Jenner Institute to develop more robust and scalable vaccine manufacturing processes.

20180412 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
28-mar-2018
Merck Named Best Bioprocessing Supplier in Asia

Merck was named the overall “Best Bioprocessing Supplier” and won the sub-category of “Best Bioprocessing Supplier Award for Single-use Systems” at the Asia-Pacific Bioprocessing Excellence Awards 2018 ceremony.

20180328 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
05-mar-2018
Merck and Schneider Electric Sign MoU to Advance China’s Biopharmaceutical Industry

Merck and Schneider Electric, a global specialist in energy management and automation, today announced the signing of a Memorandum of Understanding (MoU) that aims to automate the mAb process for China’s biopharmaceutical industry.

20180305 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
27-feb-2018
Merck Announces €300,000 in Grants to Accelerate Therapeutic Research in Life Science

Merck today announced the recipients of its Emerging Biotech Grant Program in China.

20180227 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
26-feb-2018
MilliporeSigma Announces 2018 North American Curiosity Cube™ Mobile Science Lab Tour

MilliporeSigma today announced plans for its second annual Curiosity Cube™ mobile science lab tour, which will kick off in February and visit more than 100 communities in the U.S. and Canada.

20180226 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
22-feb-2018
Merck Announces Investment in India with New Life Science Manufacturing & Distribution Centre

Merck today announced that it will invest €16.6 million in its new manufacturing and distribution centre for the Life Science business, located near Mumbai, India.

20180222 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
22-feb-2018
Merck Signs Agreement with Incheon Free Economic Zone to Build Cell Culture Facility in South Korea

Merck today announced it has signed an agreement with Incheon Free Economic Zone (IFEZ) to build an integrated cell culture facility in Songdo, Incheon.

20180222 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
22-feb-2018
Merck Accelerates Mobius® Single-Use Manufacturing in Wuxi

Merck today announced an additional investment to accelerate Mobius® single-use manufacturing in Wuxi, China.

20180222 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
20-feb-2018
Merck Receives Two More Patents for CRISPR Technology

Merck today announced that the Korean Intellectual Property Office and the Israel Patent Office have each issued notices granting Merck’s patent applications for the company’s CRISPR technology.

20180220 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
13-feb-2018
Merck Launches Viresolve® Barrier Capsule Filters to Protect Against Bioreactor Contamination

Merck today introduced Viresolve® Barrier capsule filters to reduce the risk of bioreactor contamination.

20180213 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
Ver todas las novedades
 
Successful Drug Development with Synthetic Lipids: Critical Aspects and Strategies

Webinar:
Successful Drug Development with Synthetic Lipids:
Critical Aspects and
Strategies

Register Now
Webinar: Smart Labels - Digital Innovation by Raw Material Suppliers to Support Drug Manufacturers’ Processes

Webinar:
Smart Labels – Digital Innovation by Raw Material Suppliers to Support Drug Manufacturers’ Processes

Watch Now
Explore, Learn, Collaborate: M Lab® Collaboration Centers - Take a tour!

Eventos

may 08
05/08/18 - 05/09/18
PDA Virus Forum
Hilton Florence Metropole
Florence, Italy
Fabricación biofarmcéutica Europa 20180508
may 08
05/08/18 - 05/09/18
4th Annual Formulation & Drug Delivery Congress
One Drummond Place, Victoria
London, UK
Fabricación biofarmcéutica Europa 20180508
abr 24
04/24/18 - 04/25/18
Pharma Congress Production & Technology
Crowne Plaza (former Swissôtel) Düsseldorf / Neuss Congress Center
Düsseldorf, Germany
Fabricación biofarmcéutica Europa 20180424
abr 23
04/23/18 - 04/25/18
Bioprocess International European Summit
Amsterdam RAI Exhibition and Convention Center
Amsterdam, The Netherlands
Fabricación biofarmcéutica Europa 20180423